Robert Everley

Robert Everley has extensive work experience in the field of proteomics and chemical biology. Robert is currently working as the Senior Director of Chemical Biology at Frontier Medicines since August 2021. Prior to this, they worked at Pfizer for four years as the Proteomics Lead in the Hit Discovery & Optimization Group. Before joining Pfizer, Robert was associated with Harvard Medical School, where they served as the Director of Proteomics in the Laboratory of Systems Pharmacology from December 2014 to June 2017. Robert also worked as a Research Fellow in the same institution's Department of Cell Biology from February 2010 to December 2014. Additionally, they have experience as a Research Fellow at Boston Children's Hospital and as a Research Intern at Aegis Sciences Corporation.

Robert Everley earned a Bachelor of Science (BS) degree in Forensic Science from Eastern Kentucky University, where they studied from 1999 to 2003. Robert later pursued a Doctor of Philosophy (Ph.D.) in Chemistry at Virginia Commonwealth University, completing their studies between 2003 and 2008.